• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

操纵大师:病毒对免疫突触的调节。

Masters of manipulation: Viral modulation of the immunological synapse.

机构信息

Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

出版信息

Cell Microbiol. 2018 Oct;20(10):e12944. doi: 10.1111/cmi.12944.

DOI:10.1111/cmi.12944
PMID:30123959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6492149/
Abstract

In order to thrive, viruses have evolved to manipulate host cell machinery for their own benefit. One major obstacle faced by pathogens is the immunological synapse. To enable efficient replication and latency in immune cells, viruses have developed a range of strategies to manipulate cellular processes involved in immunological synapse formation to evade immune detection and control T-cell activation. In vitro, viruses such as human immunodeficiency virus 1 and human T-lymphotropic virus type 1 utilise structures known as virological synapses to aid transmission of viral particles from cell to cell in a process termed trans-infection. The formation of the virological synapse provides a gateway for virus to be transferred between cells avoiding the extracellular space, preventing antibody neutralisation or recognition by complement. This review looks at how viruses are able to subvert intracellular signalling to modulate immune function to their advantage and explores the role synapse formation has in viral persistence and cell-to-cell transmission.

摘要

为了繁荣,病毒已经进化出操纵宿主细胞机制来为自己谋取利益。病原体面临的一个主要障碍是免疫突触。为了在免疫细胞中实现高效复制和潜伏,病毒已经开发了一系列策略来操纵涉及免疫突触形成的细胞过程,以逃避免疫检测和控制 T 细胞激活。在体外,人类免疫缺陷病毒 1 和人类 T 淋巴细胞性病毒 1 等病毒利用称为病毒突触的结构来辅助病毒颗粒从一个细胞传递到另一个细胞,这一过程称为转感染。病毒突触的形成提供了一个通道,使病毒能够在细胞间转移,从而避免了细胞外空间,防止了抗体中和或补体的识别。这篇综述探讨了病毒如何能够颠覆细胞内信号转导,从而调节免疫功能以利于自身,并探讨了突触形成在病毒持续存在和细胞间传播中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/7162369/d088672fc58b/CMI-20-e12944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/7162369/d088672fc58b/CMI-20-e12944-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b1f/7162369/d088672fc58b/CMI-20-e12944-g001.jpg

相似文献

1
Masters of manipulation: Viral modulation of the immunological synapse.操纵大师:病毒对免疫突触的调节。
Cell Microbiol. 2018 Oct;20(10):e12944. doi: 10.1111/cmi.12944.
2
Vesicle traffic to the immunological synapse: a multifunctional process targeted by lymphotropic viruses.囊泡向免疫突触的运输:淋巴病毒靶向的多功能过程。
Curr Top Microbiol Immunol. 2010;340:191-207. doi: 10.1007/978-3-642-03858-7_10.
3
Identification of Host Trafficking Genes Required for HIV-1 Virological Synapse Formation in Dendritic Cells.鉴定 HIV-1 病毒突触形成过程中树突状细胞所需的宿主趋化因子基因。
J Virol. 2020 Apr 16;94(9). doi: 10.1128/JVI.01597-19.
4
HIV-1 at the immunological and T-lymphocytic virological synapse.免疫和T淋巴细胞病毒学突触处的HIV-1。
Biol Chem. 2008 Oct;389(10):1253-60. doi: 10.1515/BC.2008.143.
5
TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse.树突状细胞 TLR-4 的交联赋予 BST-2/ tetherin 通过病毒学突触对 CD4+ T 细胞中 HIV-1 感染的限制。
Retrovirology. 2013 Jan 11;10:6. doi: 10.1186/1742-4690-10-6.
6
The scaffolding protein Dlg1 is a negative regulator of cell-free virus infectivity but not of cell-to-cell HIV-1 transmission in T cells.支架蛋白Dlg1 是游离病毒感染力的负调节剂,但不是 T 细胞中细胞间 HIV-1 传播的负调节剂。
PLoS One. 2012;7(1):e30130. doi: 10.1371/journal.pone.0030130. Epub 2012 Jan 17.
7
DC-T cell virological synapses and the skin: novel perspectives in dermatology.树突状细胞- T细胞病毒学突触与皮肤:皮肤病学的新视角
Exp Dermatol. 2015 Jan;24(1):1-4. doi: 10.1111/exd.12511. Epub 2014 Nov 11.
8
Dangerous liaisons at the virological synapse.病毒突触中的危险关联。
J Clin Invest. 2004 Sep;114(5):605-10. doi: 10.1172/JCI22812.
9
Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse.1型人嗜T淋巴细胞病毒的tax蛋白可引发病毒学突触中的微管重新定向。
J Biol Chem. 2005 Aug 19;280(33):29653-60. doi: 10.1074/jbc.M502639200. Epub 2005 Jun 23.
10
Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.人类嗜T细胞病毒2型合并感染对1型HIV感染患者病毒学和免疫学参数的影响。
Clin Infect Dis. 2007 Jan 1;44(1):105-10. doi: 10.1086/510076. Epub 2006 Nov 21.

引用本文的文献

1
The Assembly of HTLV-1-How Does It Differ from HIV-1?HTLV-1 衣壳的组装——它与 HIV-1 有何不同?
Viruses. 2024 Sep 27;16(10):1528. doi: 10.3390/v16101528.
2
Tumor Cell Communications as Promising Supramolecular Targets for Cancer Chemotherapy: A Possible Strategy.肿瘤细胞通讯作为癌症化疗有前途的超分子靶点:一种可能的策略。
Int J Mol Sci. 2024 Sep 27;25(19):10454. doi: 10.3390/ijms251910454.
3
The role of tunneling nanotubes during early stages of HIV infection and reactivation: implications in HIV cure.隧道纳米管在HIV感染和再激活早期阶段的作用:对HIV治愈的影响。

本文引用的文献

1
Live Imaging of HIV-1 Transfer across T Cell Virological Synapse to Epithelial Cells that Promotes Stromal Macrophage Infection.活细胞成像观察 HIV-1 经 T 细胞病毒学突触转移至上皮细胞促进基质巨噬细胞感染
Cell Rep. 2018 May 8;23(6):1794-1805. doi: 10.1016/j.celrep.2018.04.028.
2
Nanoparticle vaccines against viral infections.针对病毒感染的纳米颗粒疫苗。
Arch Virol. 2018 Sep;163(9):2313-2325. doi: 10.1007/s00705-018-3856-0. Epub 2018 May 4.
3
HIV-1 replicates and persists in vaginal epithelial dendritic cells.HIV-1 在阴道上皮树突状细胞中复制和持续存在。
NeuroImmune Pharm Ther. 2023 Jan 4;2(2):169-186. doi: 10.1515/nipt-2022-0015. eCollection 2023 Jun.
4
From the Catastrophic Objective Irreproducibility of Cancer Research and Unavoidable Failures of Molecular Targeted Therapies to the Sparkling Hope of Supramolecular Targeted Strategies.从癌症研究的灾难性客观不可重复性和分子靶向治疗不可避免的失败,到超分子靶向策略的耀眼希望。
Int J Mol Sci. 2023 Feb 1;24(3):2796. doi: 10.3390/ijms24032796.
5
The Immunological Synapse: An Emerging Target for Immune Evasion by Bacterial Pathogens.免疫突触:细菌病原体免疫逃逸的新兴靶点。
Front Immunol. 2022 Jul 13;13:943344. doi: 10.3389/fimmu.2022.943344. eCollection 2022.
6
G2-S16 Polyanionic Carbosilane Dendrimer Can Reduce HIV-1 Reservoir Formation by Inhibiting Macrophage Cell to Cell Transmission.G2-S16 聚阴离子碳硅烷树状大分子通过抑制巨噬细胞细胞间传播减少 HIV-1 储存库的形成。
Int J Mol Sci. 2021 Aug 4;22(16):8366. doi: 10.3390/ijms22168366.
7
FIB-SEM as a Volume Electron Microscopy Approach to Study Cellular Architectures in SARS-CoV-2 and Other Viral Infections: A Practical Primer for a Virologist.FIB-SEM 作为一种体积电子显微镜方法,用于研究 SARS-CoV-2 和其他病毒感染中的细胞结构:病毒学家的实用入门指南。
Viruses. 2021 Apr 2;13(4):611. doi: 10.3390/v13040611.
8
Lipid rafts and pathogens: the art of deception and exploitation.脂筏与病原体:欺骗与利用的艺术。
J Lipid Res. 2020 May;61(5):601-610. doi: 10.1194/jlr.TR119000391. Epub 2019 Oct 15.
J Clin Invest. 2018 Aug 1;128(8):3439-3444. doi: 10.1172/JCI98943. Epub 2018 Jul 9.
4
Nano-Medicine as a Newly Emerging Approach to Combat Human Immunodeficiency Virus (HIV).纳米医学作为一种对抗人类免疫缺陷病毒(HIV)的新兴方法。
Pharm Nanotechnol. 2018;6(1):17-27. doi: 10.2174/2211738506666180209095710.
5
Snapin promotes HIV-1 transmission from dendritic cells by dampening TLR8 signaling.Snapin通过抑制TLR8信号传导促进HIV-1从树突状细胞的传播。
EMBO J. 2017 Oct 16;36(20):2998-3011. doi: 10.15252/embj.201695364. Epub 2017 Sep 18.
6
DC-SIGN promotes Japanese encephalitis virus transmission from dendritic cells to T cells via virological synapses.树突细胞表面特异性免疫球蛋白样凝集素促进日本脑炎病毒通过病毒学突触在树突细胞和 T 细胞间的传播。
Virol Sin. 2017 Dec;32(6):495-502. doi: 10.1007/s12250-017-4034-3. Epub 2017 Aug 31.
7
Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.人呼吸道合胞病毒毒力因子对宿主免疫的调节:对固有免疫和适应性免疫的协同抑制
Front Cell Infect Microbiol. 2017 Aug 16;7:367. doi: 10.3389/fcimb.2017.00367. eCollection 2017.
8
The role of nanotechnology in the treatment of viral infections.纳米技术在病毒感染治疗中的作用。
Ther Adv Infect Dis. 2017 Jul;4(4):105-131. doi: 10.1177/2049936117713593. Epub 2017 Jul 5.
9
Vaccine nanoparticles for protection against HIV infection.用于预防HIV感染的疫苗纳米颗粒。
Nanomedicine (Lond). 2017 Mar;12(6):673-682. doi: 10.2217/nnm-2016-0381. Epub 2017 Feb 21.
10
Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.针对具有传播奠基者Env的HIV-1细胞间传播的广谱中和抗体的效力降低及中和不完全
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02425-16. Print 2017 May 1.